11 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MuscleView
FDA 510(k)
FDA Class 2
·Radiology
LCP
FDA UDI
Synthes GmbH·10886982166814·LCP ONE-THIRD TUBULAR PLATE WITH COLLAR 3 HOLES...
NA
FDA UDI
MEDTRONIC PS MEDICAL, INC.·00643169497498·SHUNT 24133-1 CSF-DELTA CHMBR PERIT 1.0
BIOPSY SCIENCES, LLC, LUNG BIOPSY SITE MARKER
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
BIOMET ORTHOPAEDIC SALVAGE SYSTEM (OSS)
FDA 510(k)
FDA Class 2
·Orthopedic
TRUE METRIX
FDA Adverse Event
Malfunction
·TRIVIDIA HEALTH INC·Product code NBW·May 17, 2024
POSEY KEEPSAFE DELUXE ALARM
FDA Adverse Event
Malfunction
·J. T. POSEY CO.·Product code KMI·September 2, 2011
INSULIN INFUSION PUMP
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·November 10, 2014
EMERGE?
FDA Adverse Event
Malfunction
·BOSTON SCIENTIFIC - MAPLE GROVE·Product code LOX·July 22, 2013
Malleable C- Retractor, Part Number 397.232, used to provide retraction of the soft tissues during use of trocar instrumentation. Used in the following systems: the Basic Trocar System, Universal Trocar System, Craniofacial Modular Fixation System, Craniofacial (CMF) Distraction System, MatrixORTHOGNATHIC Plating System, and the Matrix MANDIBLE Plating System.
FDA Enforcement
Class II
·Terminated·Synthes, Inc.·January 21, 2015
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014